Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21)

The summary for the Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.

Collaborative HIV/AIDS Studies in the Middle East and North Africa (R21): Purpose. This Funding Opportunity Announcement (FOA) is issued by the National Institute of Mental Health (NIMH), National Institute on Drug Abuse (NIDA), National Institute of Allergy and Infectious Diseases (NIAID), National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute of Child Health and Human Development (NICHD), and the Fogarty International Center (FIC). The Fogarty International Center will accept only secondary assignments for potential co-funding with an Institute designated as primary assignee. The aim of this FOA is to invite applications for collaborations for exploratory and developmental work on HIV/AIDS in the low and middle income countries of the Middle East and North Africa (MENA), as defined by the World Bank: Algeria, Djibouti, Egypt, Iran, Iraq, Jordan, Lebanon, Libya, Morocco, Oman, Syria, Tunisia, West Bank and Gaza, and Yemen. Specific areas of research include, but aren't limited to, epidemiologic studies, prevention research from both biomedical and social/behavioral perspectives, studies of social factors affecting the spread of HIV in the region, and research on women and youth. Collaborations must involve U.S. investigators from a partnering U.S. organization and one or more research teams in the MENA region. The collaborative effort supported through the R21 should help foster the development of HIV-relevant research infrastructure and expertise in the region and have the potential to lead to further research and improvements in public health.